BrianROttMD

Professor in the Department of Neurology at the Warren Alpert Medical School of Brown University Directs the Alzheimer's Disease & Memory Disorders Center at Rhode Island Hospital

Join to view full profile

Dr. Ott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ott's full profile

Already have an account?

Office
593 Eddy St
# Apc
Providence, RI 02903
Phone+1 401-444-4000

Fax+1 401-793-8312

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1982 - 1985
Roger Williams Medical CenterResidency, Internal Medicine, 1979 - 1982
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979

Certifications & Licensure

RI State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Completed
Phase 3
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

Knowledge and Attitudes toward New Disease-Modifying Treatments for Alzheimer's Disease among Nursing Home Directors.
Shiwei Liang, Brian R Ott, Jennifer Tjia, Kate L Lapane, Alison C Rataj
Journal of the American Medical Directors Association. 2025-01-01
1 citations
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab.
André Zimerman, Michelle L O'Donoghue, Xinhui Ran, KyungAh Im, Brian R Ott
NEJM Evidence. 2025-01-01
Medication Changes Among Older Drivers Involved in Motor Vehicle Crashes.
Andrew R Zullo, Melissa R Riester, Adam M D'Amico, Monika Reddy Bhuma, Marzan A Khan
JAMA Network Open. 2024-10-01

Press Mentions

Arc of Trump’s Coronavirus Comments Defies Reality on GroundMarch 15th, 2020
Clinical Trials with Volunteers Seek to Conquer Alzheimer’s and Other Memory DisordersOctober 28th, 2019
Symposium on Lifestyle Risk Factors for Dementia Set Nov. 7 at RadissonOctober 24th, 2019
Join now to see all

Grant Support

Naturalistic Assessment Of The Driving Ability Of Cognitively Impaired EldersNational Institute On Aging2009–2010
"Naturalistic Assessment Of The Driving Ability Of Cognitively Impaired EldersNational Institute On Aging2007–2008
A Longitudinal Study Of Hazardous Drivers With DementiaNational Institute On Aging2004
A Longitudinal Study Of Hazardous Drivers With DementiaNational Institute On Aging2001–2004